TALLAHASSEE, FLORIDA – MAY 21, 2025 – Susan G. Komen®, the world’s leading breast cancer organization, today issued the following statement on the passage of critical breast imaging legislation in Florida, SB 158. Diagnostic and supplemental imaging is a critical form of breast cancer screening for some high-risk individuals and an important step in determining the need for a biopsy to rule out or confirm breast cancer. SB 158 was approved by the Florida legislature and has now been signed into law by Governor Ron DeSantis.
“We commend the legislature and Governor DeSantis for eliminating barriers to essential care so that people with state-regulated health plans are able to receive their medically necessary diagnostic and supplemental imaging without the financial burden of high patient cost sharing,” said Molly Guthrie, Vice President of Policy and Advocacy at Susan G. Komen.
“Thousands of Floridians require diagnostic and supplemental breast imaging every year, yet many forgo these critical services due to high out-of-pocket costs. Not anymore. This life-saving legislation means they can now receive the breast imaging they require, likely leading to an earlier breast cancer diagnosis and often better health outcomes.”
“Komen will continue to advocate for legislation that ensures fair and equitable access to high-quality and affordable breast care for all.”
